Literature DB >> 33348604

How Ah Receptor Ligand Specificity Became Important in Understanding Its Physiological Function.

Iain A Murray1, Gary H Perdew1.   

Abstract

Increasingly, the aryl hydrocarbon receptor (AHR) is being recognized as a sensor for endogenous and pseudo-endogenous metabolites, and in particular microbiota and host generated tryptophan metabolites. One proposed explanation for this is the role of the AHR in innate immune signaling within barrier tissues in response to the presence of microorganisms. A number of cytokine/chemokine genes exhibit a combinatorial increase in transcription upon toll-like receptors and AHR activation, supporting this concept. The AHR also plays a role in the enhanced differentiation of intestinal and dermal epithelium leading to improved barrier function. Importantly, from an evolutionary perspective many of these tryptophan metabolites exhibit greater activation potential for the human AHR when compared to the rodent AHR. These observations underscore the importance of the AHR in barrier tissues and may lead to pharmacologic therapeutic intervention.

Entities:  

Keywords:  AHR; Ah receptor; agonist; cytokines; indole; microbiome; tryptophan

Year:  2020        PMID: 33348604     DOI: 10.3390/ijms21249614

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  11 in total

1.  Cinnabarinic Acid Provides Hepatoprotection Against Nonalcoholic Fatty Liver Disease.

Authors:  Nikhil Y Patil; Iulia Rus; Emma Downing; Ashok Mandala; Jacob E Friedman; Aditya D Joshi
Journal:  J Pharmacol Exp Ther       Date:  2022-08-06       Impact factor: 4.402

Review 2.  Current Therapeutic Landscape and Safety Roadmap for Targeting the Aryl Hydrocarbon Receptor in Inflammatory Gastrointestinal Indications.

Authors:  Samantha C Faber; Tejas S Lahoti; Ewan R Taylor; Lauren Lewis; Jessica M Sapiro; Vicencia Toledo Sales; Yvonne P Dragan; Brandon D Jeffy
Journal:  Cells       Date:  2022-05-21       Impact factor: 7.666

3.  Hexokinase 2 is a transcriptional target and a positive modulator of AHR signalling.

Authors:  Manon Watzky; Solène Huard; Ludmila Juricek; Julien Dairou; Caroline Chauvet; Xavier Coumoul; Anne Letessier; Benoit Miotto
Journal:  Nucleic Acids Res       Date:  2022-06-10       Impact factor: 19.160

Review 4.  The Aryl Hydrocarbon Receptor in Energy Balance: The Road from Dioxin-Induced Wasting Syndrome to Combating Obesity with Ahr Ligands.

Authors:  Nathaniel G Girer; Craig R Tomlinson; Cornelis J Elferink
Journal:  Int J Mol Sci       Date:  2020-12-23       Impact factor: 6.208

Review 5.  The Aryl Hydrocarbon Receptor (AHR): A Novel Therapeutic Target for Pulmonary Diseases?

Authors:  Binoy Shivanna; Chun Chu; Bhagavatula Moorthy
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

6.  Glycogen Synthase Kinase 3 Beta Regulates the Human Aryl Hydrocarbon Receptor Cellular Content and Activity.

Authors:  Yujie Yang; William K Chan
Journal:  Int J Mol Sci       Date:  2021-06-05       Impact factor: 5.923

Review 7.  Species-Specific Differences in Aryl Hydrocarbon Receptor Responses: How and Why?

Authors:  Xiaoting Xu; Xi Zhang; Yuzhu Yuan; Yongrui Zhao; Hamza M Fares; Mengjiao Yang; Qing Wen; Reham Taha; Lixin Sun
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

Review 8.  What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis.

Authors:  Raymond Vanholder; Sanjay K Nigam; Stéphane Burtey; Griet Glorieux
Journal:  Toxins (Basel)       Date:  2022-03-17       Impact factor: 4.546

Review 9.  The aryl hydrocarbon receptor in liver inflammation.

Authors:  Antonella Carambia; Fenja Amrei Schuran
Journal:  Semin Immunopathol       Date:  2021-06-01       Impact factor: 9.623

10.  The aryl hydrocarbon receptor at the forefront of host-microbe interactions in the skin: A perspective on current knowledge gaps and directions for future research and therapeutic applications.

Authors:  Ellen H van den Bogaard; Charlotte Esser; Gary H Perdew
Journal:  Exp Dermatol       Date:  2021-07-08       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.